Andrew Scott

4.5k total citations · 2 hit papers
18 papers, 3.2k citations indexed

About

Andrew Scott is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Andrew Scott has authored 18 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Andrew Scott's work include Migraine and Headache Studies (3 papers), Analytical Chemistry and Chromatography (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Andrew Scott is often cited by papers focused on Migraine and Headache Studies (3 papers), Analytical Chemistry and Chromatography (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Andrew Scott collaborates with scholars based in United Kingdom, United States and Australia. Andrew Scott's co-authors include Munir Pirmohamed, Thomas Walley, Alasdair Breckenridge, B Kevin Park, Chris Green, Keith Farrar, Maria C. Moschella, Barbara E. Ehrlich, Mark Landers and Thottala Jayaraman and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Clinical Pharmacokinetics.

In The Last Decade

Andrew Scott

17 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

2004 2.3k citations Munir Pirmohamed, Chris Green et al. BMJ profile →
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein

1994 679 citations Karol Ondriaš, Andrew Scott et al. Cell profile →

Peers

Andrew Scott

GG

TOXIC

MB

PPCH

CCM

Staffan Hägg Sweden

B Kevin Park United Kingdom

Philip A. Routledge United Kingdom

Jason Lazarou Canada

Hubert G.M. Leufkens Netherlands

Thomas Walley United Kingdom

Keith Farrar United Kingdom

Saad Shakir United Kingdom

Corinne M. Hohl Canada

Annie Fourrier‐Réglat France

Staffan Hägg Sweden

Andrew Scott

787 ×0.7

GG

723 ×0.8

TOXIC

336 ×0.4

MB

623 ×0.9

PPCH

531 ×1.0

CCM

Citations per year, relative to Andrew Scott Andrew Scott (= 1×) peers Staffan Hägg

Countries citing papers authored by Andrew Scott

Since Specialization

Citations

This map shows the geographic impact of Andrew Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Scott more than expected).

Fields of papers citing papers by Andrew Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Scott. The network helps show where Andrew Scott may publish in the future.

Co-authorship network of co-authors of Andrew Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Scott. A scholar is included among the top collaborators of Andrew Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Scott. Andrew Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Khair, Kate, et al.. (2016). Patient and caregiver perceptions of a pre-filled diluent syringe (MixPro®). 3(1). 33–38. 2 indexed citations

2.

Brodie, Martin J., Jacqueline A. French, Susan A. McDonald, et al.. (2014). Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability. Epilepsy Research. 108(5). 989–994. 6 indexed citations

3.

Pirmohamed, Munir, Chris Green, Andrew Scott, et al.. (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 329(7456). 15–19. 2286 indexed citations breakdown →

4.

Scott, Andrew. (2004). Hypertension in older adults. Reviews in Clinical Gerontology. 14(3). 189–198. 3 indexed citations

5.

Hoshiya, Yasunori, Vandana Gupta, Hirofumi Kawakubo, et al.. (2003). Mullerian Inhibiting Substance Promotes Interferon γ-induced Gene Expression and Apoptosis in Breast Cancer Cells. Journal of Biological Chemistry. 278(51). 51703–51712. 25 indexed citations

6.

Salonen, R & Andrew Scott. (2002). Triptans: Do they differ?. Current Pain and Headache Reports. 6(2). 133–139. 8 indexed citations

7.

Scott, Andrew. (1997). Hypertension in the Older Adult. Medical Entomology and Zoology. 1 indexed citations

8.

Walley, T & Andrew Scott. (1995). Prescribing in the elderly. Postgraduate Medical Journal. 71(838). 466–471. 30 indexed citations

9.

Ondriaš, Karol, Andrew Scott, Evgeny Kobrinsky, et al.. (1994). Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 77(4). 513–523. 679 indexed citations breakdown →

10.

Scott, Andrew. (1994). Sumatriptan Clinical Pharmacokinetics. Clinical Pharmacokinetics. 27(5). 337–344. 64 indexed citations

11.

Scott, Andrew. (1993). Stereoisomers and Drug Toxicity. Drug Safety. 8(2). 149–159. 41 indexed citations

12.

Scott, Andrew. (1992). Dihydroergotamine. Clinical Neuropharmacology. 15(4). 289–296. 29 indexed citations

13.

Jamieson, M. J., et al.. (1990). The measurement of blood pressure: sitting or supine, once or twice?. Journal of Hypertension. 8(7). 635–640. 38 indexed citations

14.

Scott, Andrew. (1990). Stereoisomers in Clinical Pharmacology. Drug Information Journal. 24(1). 121–123. 3 indexed citations

15.

White, Pamela, et al.. (1989). The Bioavailability of a Mixed Micellar Preparation of Vitamin K1, and its Procoagulant Effect in Anticoagulated Rabbits. Journal of Pharmacy and Pharmacology. 41(4). 257–260. 4 indexed citations

16.

Scott, Andrew, et al.. (1988). Changes in rat hepatic UDP-glucuronosyltransferase activity after induction of hyper- or hypothyroidism are substrate dependent. Biochemical Society Transactions. 16(5). 802–803. 4 indexed citations

17.

Nuttall, Mark, Andrew Scott, & Heather Wallace. (1986). A study of the diurnal variation of polyamines in blood and urine in normal individuals. Biochemical Society Transactions. 14(1). 117–117. 1 indexed citations

18.

Scott, Andrew, et al.. (1981). Clinical pharmacology: drug absorption.. BMJ. 282(6262). 462–463. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact